REFRESH: Research Framework Exploring Sleep Health

Sponsor
Scripps Translational Science Institute (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05197738
Collaborator
(none)
100,000
239.5

Study Details

Study Description

Brief Summary

This is a digital health study in which participants are recruited to collect sleep and activity data from digital activity trackers. We are also collecting survey/questionnaire data on baseline health and sleep characteristics as well as bi-weekly assessments of sleep quality and mood. Overall, we aim to examine how sleep relates to physical and mental health in a large population of activity tracker users.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    100000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Research Framework Exploring Sleep Health
    Anticipated Study Start Date :
    Jan 15, 2022
    Anticipated Primary Completion Date :
    Dec 31, 2026
    Anticipated Study Completion Date :
    Dec 31, 2041

    Arms and Interventions

    Arm Intervention/Treatment
    High risk OSA

    Cohort of individuals found to sleep have scores categorized as "High risk," on the Berlin questionnaire.

    Low risk OSA

    Cohort of individuals found to sleep have scores categorized as "Low risk," on the Berlin questionnaire.

    Short sleepers

    Cohort of individuals found to have average sleep duration of < 7 hours per night. Individuals who sleep on average less than 6 hours per night will further be sub-categorized as very short sleeprs.

    Long sleepers

    Cohort of individuals found to have average sleep duration of >9 hours per night.

    Average lengths leepers

    Cohort of individuals found to have an average sleep duration between 7 and 9 hours per night

    Regular sleepers

    Cohort of individuals whose standard deviation of sleep duration falls within 1 standard deviation of their mean sleep duration.

    Irregular sleepers

    Cohort of individuals whose standard deviation of sleep duration falls greater than 1 standard deviation of their mean sleep duration

    Severe insomnia risk

    Cohort of individuals whose scores on the Insomnia Severity Index would be categorized as severe

    Moderate insomnia risk

    Cohort of individuals whose scores on the Insomnia Severity Index would be categorized as moderate

    No insomnia risk

    Cohort of individuals whose scores on the Insomnia Severity Index would be categorized as low

    Increased social jet lag

    Individuals who are more than 1 hour less or more of sleep on weekdays compared to average weekend sleep.

    Outcome Measures

    Primary Outcome Measures

    1. Patient Health Questionnaire 9 [Administered one time at enrollment]

      Baseline depression scores on a scale from 0 to 27, which higher scores indicated more depression

    2. Bi-weekly mood scores [Averaged bi-weekly over a two month period]

      Mood scores based on an 11 point rating scale, with higher scores indicated a better mood

    3. Subjective sleep quality [Averaged bi-weekly over a two month period]

      Biweekly assessment of refreshing sleep quality on an 11 point rating scale, with higher scores indicated better subjective sleep from the participant

    4. Change in BMI [Measured as the difference between BMI reported at the beginning of the study and at the two-month mark.]

      Based on standard BMI categories; calculated based on self-reported data of height and weight

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age ≥ 18 years

    • Residing within the United States

    • Ability to use the REFRESH app on the participant's own smartphone device

    Exclusion Criteria:
    • In-ability to consent

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Scripps Translational Science Institute

    Investigators

    • Principal Investigator: Stuti Jaiswal, MD, PhD, Scripps Research Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Stuti Jaiswal, Assistant Professor of Molecular Medicine, Scripps Translational Science Institute
    ClinicalTrials.gov Identifier:
    NCT05197738
    Other Study ID Numbers:
    • IRB-21-7863
    First Posted:
    Jan 19, 2022
    Last Update Posted:
    Jan 19, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 19, 2022